2016
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?
Abstract: Background While the inverse association between high-density lipoprotein cholesterol (HDL-C) and risk of (CVD) has been long established, it remains unclear whether low HDL-C remains a CVD risk factor when levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) are not elevated. This is a timely issue because recent studies have questioned whether HDL-C is truly an independent predictor of CVD. Methods and Results 3590 men and women from the Framingham Heart Study offspring cohort witho…
Search citation statements
Paper Sections
Select...
69
25
7
0
Citation Types
6
49
0
2
Year Published
2016
2026
Publication Types
Select...
84
6
5
5
Relationship
3
97
Authors
Journals
Cited by 98 publications
(57 citation statements)
References 46 publications
6
49
0
2
“…In addition, our nomograms, unlike these CVD risk assessment scores where total cholesterol is used as an independent predictor, included lipid spectrum indicators, such as TG, HDL-C and LDL-C. Our nomograms demonstrated that low levels of HDL-C and high levels of TG and LDL-C contribute significantly to the risk of CVD. This result is similar to the findings of Bartlett et al [ 65 ], who examined the association of low levels of HDL-C with a risk of CVD against the background of increased levels of TG and LDL-C and found that CVD risk was higher when low HDL-C was accompanied by LDL-C ≥ 100 mg/dL (OR 1.3, 95% CI: 1.0–1.6), TG ≥ 100 mg/dL (OR 1.3, 95% CI: 1.1–1.5) or both (OR 1.6, 95% CI: 1.2–2.2). Moreover, the study shown that high levels of TG increase the risk of developing CVD, regardless of the level of HDL-C and LDL-C. Another study [ 66 ] also found that increasing TG levels increased the risk of CVD, regardless of HDL-C levels, and in men there was an increase in the risk of CVD with increasing TG levels to 100 mg/dL, and in women to 200 mg/dL.…”
Section: Discussionsupporting
confidence: 93%
“…In addition, our nomograms, unlike these CVD risk assessment scores where total cholesterol is used as an independent predictor, included lipid spectrum indicators, such as TG, HDL-C and LDL-C. Our nomograms demonstrated that low levels of HDL-C and high levels of TG and LDL-C contribute significantly to the risk of CVD. This result is similar to the findings of Bartlett et al [ 65 ], who examined the association of low levels of HDL-C with a risk of CVD against the background of increased levels of TG and LDL-C and found that CVD risk was higher when low HDL-C was accompanied by LDL-C ≥ 100 mg/dL (OR 1.3, 95% CI: 1.0–1.6), TG ≥ 100 mg/dL (OR 1.3, 95% CI: 1.1–1.5) or both (OR 1.6, 95% CI: 1.2–2.2). Moreover, the study shown that high levels of TG increase the risk of developing CVD, regardless of the level of HDL-C and LDL-C. Another study [ 66 ] also found that increasing TG levels increased the risk of CVD, regardless of HDL-C levels, and in men there was an increase in the risk of CVD with increasing TG levels to 100 mg/dL, and in women to 200 mg/dL.…”
Section: Discussionsupporting
confidence: 93%
“…In spite of the low levels of HDL-C reported earlier in this population [ 26 ], HDL-C was not associated with self-reported CVD in this study. This is consistent with earlier reports which showed that isolated low HDL-C levels may not necessarily reflect CVD risk [ 49 ]. Rather, HDL-C sub-fractions have been reported to improve CVD prediction [ 50 , 51 ] Future studies are therefore recommended to investigate the relationship of HDL-C sub-fractions with CVD risk in this population.…”
Section: Discussionsupporting
confidence: 93%
“…33,34 Since APOA5 rs662799 was associated with higher HDL-c levels (Table 4) at baseline (P=0.007) and to a lesser extent following statin treatment (P=0.031), we postulated that this SNP may have a protective effect against CVD risk, as suggested previously. 35,36,37 In terms of HDL-c levels, our findings are in accordance with those of a study in the Turkish Cypriot population (n=100) which indicated that homozygous recessive GG genotypes had considerably higher HDL-c levels than other genotypes (P =0.014). 38 In addition to higher HDL-c levels, minor allele G carriers also had a lower TG level (P <0.001) after 6 months of statin treatment.…”
Section: Discussionsupporting
confidence: 91%
